Pentoxifylline Therapeutic Cheat Sheet
Pentoxifylline is a methyl-xanthine derivative traditionally used to treat symptoms of peripheral vascular disease and has emerged as a valuable therapeutic agent in dermatology for its anti-inflammatory and immunomodulatory properties. We continue our series, Therapeutic Cheat Sheet, with a closer look at pentoxifylline, which is FDA-approved for the treatment of intermittent claudication and is …
Pentoxifylline is a methyl-xanthine derivative traditionally used to treat symptoms of peripheral vascular disease and has emerged as a valuable therapeutic agent in dermatology for its anti-inflammatory and immunomodulatory properties. We continue our series, Therapeutic Cheat Sheet, with a closer look at pentoxifylline, which is FDA-approved for the treatment of intermittent claudication and is … 
A study in the September Journal of Drugs in Dermatology addressed the impact of social media algorithms on the perception of beauty. While the golden ratio dates back to ancient Greece – and is an ages-old beauty standard for those of European ancestry – beauty ideals of facial features often change over time and vary by region. Yet access to a curated diet of images through social media may … 
Chemical peels are a valuable yet underutilized treatment in dermatology, providing consistent clinical outcomes and high patient satisfaction at low overhead cost. During the 2024 Pigmentary Disorders Exchange Symposium, Dr. Seaver Soon, a Mohs micrographic surgeon and cosmetic dermatologist from San Diego, shared his expertise on superficial and medium-depth chemical peels, highlighting their te … 
At the 2024 Pigmentary Disorders Exchange Symposium in Chicago, Dr. Zoe Draelos, an expert dermatologist and research scientist, gave a comprehensive lecture on skin aging, emphasizing that photodamage is just one aspect of a broader spectrum of factors influencing skin health. Her lecture focused on understanding how various elements contribute to skin aging beyond traditional UV radiation, inclu … 
A study in the August Journal of Drugs in Dermatology addressed the burden of melasma – the populations most prone to melasma and the comorbidities associated with it. According to the study’s authors, a deeper understanding of the associations of race, ethnicity and comorbidities can help dermatologists determine which patients are at risk of developing melasma and as well as potential new pa … 